Chelsea Therapeutics International, Ltd. 4 SEC Filings

Filed On	Filing
25 Jun 2014	Form 4: Stoll Roger G Phd, Director Disposed of 40,000 shares (Tender Offer) · Disposed of 310,000 Stock Option (Right to Buy) (Disposition to Issuer)
25 Jun 2014	Form 4: Hewitt L Arthur, Chief Scientific Officer Disposed of 58,683 shares (Tender Offer) · Received 218,923 shares by exercise or conversion ($380K) · Returned 218,923 shares to the issuer · 1 more
25 Jun 2014	Form 4: Rueckert William Dodge, Director Disposed of 50,000 shares (Tender Offer) · Disposed of 280,000 Stock Option (Right to Buy) (Disposition to Issuer)
25 Jun 2014	Form 4: Weiser Michael, Director Disposed of 450,178 shares (Tender Offer) · Received 27,500 shares by exercise or conversion ($179K) · Returned 27,500 shares to the issuer · 1 more
25 Jun 2014	Form 4: Clemens Kevan, Director Disposed of 5,000 shares (Tender Offer) · Disposed of 465,210 Stock Option (Right to Buy) (Disposition to Issuer)
25 Jun 2014	Form 4: Schmidt Keith, Chief Commercial Officer Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) ($194K)
25 Jun 2014	Form 4: Roberts Michael J, VP, Business Development Disposed of 22,000 shares (Tender Offer) · Received 109,878 shares by exercise or conversion ($99.9K) · Returned 109,878 shares to the issuer · 1 more
25 Jun 2014	Form 4: Oliveto Joseph, Director Disposed of 3,500 shares (Tender Offer) · Received 490,000 shares by exercise or conversion ($980K) · Returned 490,000 shares to the issuer · 1 more
25 Jun 2014	Form 4: Riehle J Nick, Chief Financial Officer Disposed of 66,183 shares (Tender Offer) · Received 368,923 shares by exercise or conversion ($1.02M) · Returned 368,923 shares to the issuer · 1 more
25 Jun 2014	Form 4: Schwieterman William D, Chief Medical Officer Disposed of 130,592 shares (Tender Offer) · Received 350,000 shares by exercise or conversion ($1.04M) · Returned 350,000 shares to the issuer · 1 more
30 Jan 2014	Form 4: Schmidt Keith, Chief Commercial Officer Granted 100,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Roberts Michael J, VP, Business Development Granted 50,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Schwieterman William D, Chief Medical Officer Granted 50,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Hewitt L Arthur, Chief Scientific Officer Granted 50,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Riehle J Nick, Chief Financial Officer Granted 50,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Oliveto Joseph, Director Granted 150,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Stoll Roger G Phd, Director Granted 35,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Rueckert William Dodge, Director Granted 35,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Clemens Kevan, Director Granted 35,000 Stock Option (Right to Buy)
24 Jan 2014	Form 4: Weiser Michael, Director Granted 52,500 Stock Option (Right to Buy)

Comments